Home > Healthcare > Medical Devices > Diagnostic Devices > Sleep Apnea Devices Market

Sleep Apnea Devices Market - By Product (Therapeutics, Diagnostics {Polysomnography Device, Respiratory Polygraph}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals) & Global Forecast, 2023-2032

  • Report ID: GMI489
  • Published Date: Mar 2023
  • Report Format: PDF

Sleep Apnea Devices Market Size

Sleep Apnea Devices Market size exceeded USD 7.5 billion in 2022. The industry is anticipated to grow at over 7.5% CAGR from 2023 to 2032 driven by supportive product innovation strategies adopted by key industry players.
 

Sleep Apnea Devices Market

The product demand is primarily fueled by increasing awareness regarding sleep apnea and other sleep disorders. The demand for early-stage diagnosis due to the rising knowledge associated with sleep disorders and their health consequences among people is expected to promote the market revenue. In addition, several government bodies, including the American Sleep Association and German Sleep Society, are initiating awareness programs to improve the quality of life for people with complex & chronic sleep disorders.
 

Clinical consequences and economic impact of sleep apnea and related sleep disorders may restrain industry progression

Undiagnosed and untreated sleep disorders can result in irregular physiological processes that can cause chronic illnesses, including an increased risk for cardiovascular disease, stroke, metabolic disorders, and high blood pressure, among other things. As per recent research studies, individuals with OSA could have increased healthcare utilization and a higher chance of being readmitted to the hospital compared to the ones receiving treatment for OSAS. Nonetheless, in the long run, the continuous emphasis of manufacturers on developing efficient, inexpensive, and acceptable new therapeutic modalities is anticipated to overcome these issues.
 

Sleep Apnea Devices Market Analysis

Global Sleep Apnea Devices Market Share by Product

Sleep apnea devices market from therapeutics segment was valued at more than USD 4.5 billion in 2022 and is likely to observe prominent growth through 2032 owing to the surging prevalence of sleep disorders as well as the escalating demand for novel therapeutics in sleep apnea management. Moreover, consistent efforts by major companies to develop technologically advanced devices to reduce inconsistencies associated with conventional devices are further fostering product adoption.
 

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for sleep apnea devices was valued at more than USD 7.5 billion in 2022 and is primed to progress at over 7.5% CAGR between 2023 and 2032 propelled by increasing awareness regarding sleep apnea and other sleep disorders.

The therapeutics segment recorded a valuation of more than USD 4.5 billion in 2022 as a result of consistent efforts by major companies to develop technologically advanced devices to reduce inconsistencies associated with conventional devices.

Leading companies in the sleep apnea devices market include Koninklijke Philips N.V., Fisher & Paykel Healthcare, Invacare Corporation, ResMed Inc., Natus Medical Inc., and Teleflex Inc., among others.

North America sleep apnea devices market is slated to garner more than USD 6 billion in revenue by 2032 attributed to the strong presence of industry players and an upsurge in the number of people suffering from sleep apnea and related co-morbidities in the region.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 30
  • Tables & Figures: 345
  • Countries covered: 13
  • Pages: 180
 Download Free Sample